Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating activities:
Net loss	$ (1,758,560)	$ (314,975)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	601,194	653,625
Stock-based compensation	22,604	25,332
Non-cash life insurance policy reduction / (accretion)	20,329	(90,406)
(Gain) loss on sale of property, plant and equipment	2,574	(8,906)
Deferred income taxes		(6,000)
Foreign currency transaction (gain) loss	8,983	(29,299)
(Increase) decrease in accounts receivable and accounts due from employees and distributors	(295,226)	98,634
(Increase) decrease in inventories	31,270	(313,382)
(Increase) decrease in refundable income taxes	3,373	49,500
(Increase) decrease in prepaid expenses and other current assets	(212,124)	(21,418)
(Increase) decrease in other assets	(63,302)	(30,196)
Increase (decrease) in income taxes payable	(5,711)	26,950
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities	794,727	(632,607)
Net cash used in operating activities	(849,869)	(593,148)
Investing activities:
Purchase of property, plant and equipment	(96,700)	(430,083)
Proceeds from the sale of property, plant and equipment	5,270	13,001
Proceeds from redemption of life insurance policy	3,066,193
Payments received on distributor note receivable	86,266	81,254
Net cash provided by (used in) investing activities	3,061,029	(335,828)
Financing activities:
Principal payments on long-term borrowings	(3,045,421)	(282,496)
Net cash used in financing activities	(3,045,421)	(282,496)
Effect of exchange rate changes on cash and cash equivalents	(65,690)	70,066
Increase (decrease) in cash and cash equivalents	(899,951)	(1,141,406)
Cash and cash equivalents at beginning of period	3,272,788	3,606,817
Cash and cash equivalents at end of period	$ 2,372,837	$ 2,465,411